Article | September 29, 2022

Ulcerative Colitis: The Asia Pacific Clinical Trial Landscape

Source: Novotech
GettyImages-1251251391 stomach

Ulcerative Colitis (UC) is one of the most common types of Inflammatory bowel disease (IBD) with idiopathic, chronic, relapsing, and remitting inflammation of the gastrointestinal tract. UC is characterized by diffuse mucosal inflammation limited to the colon. Longstanding UC is also associated with a defined risk of dysplasia and colorectal cancer, which is believed to be related to long-standing unchecked inflammation. Since 8% to 14% of UC patients have a family history of the condition, it appears that this disease has a genetic component, with a four-fold increased risk of a first-degree relative of a UC patient developing the disease. Depending on rectal bleeding, the severity of UC is rated from mild to severe. Diarrhea, often with blood or pus, abdominal pain, cramping, rectal pain, rectal bleeding-passing a small amount of blood with stool are some of the signs and symptoms of UC. Although UC is a chronic condition, overall mortality is comparable to that of the general population. (1)


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader